AI biotech preview of 2026: Clinic takes center stagenews2025-12-17T14:00:16+00:00December 17th, 2025|Endpoints News|
Post-Hoc Live: Endpoints winners and losers list for 2025news2025-12-17T13:48:27+00:00December 17th, 2025|Endpoints News|
Addition Therapeutics raises $106.5M for all RNA ‘jumping gene’ therapiesnews2025-12-17T13:22:29+00:00December 17th, 2025|Endpoints News|
Chemistry department woes, Trump, Gen AI and pollution capture headlines in 2025news2025-12-17T12:29:00+00:00December 17th, 2025|Chemistry World|
Hansa’s enzyme therapy flunks Phase 3 trial in rare kidney diseasenews2025-12-17T11:20:22+00:00December 17th, 2025|Endpoints News|
